Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1.0 35 38 35 38 B-lower_bound
x 39 40 39 40 I-lower_bound
10 41 43 41 43 I-lower_bound
^ 43 44 43 44 I-lower_bound
9 44 45 44 45 I-lower_bound
/L 46 48 46 48 I-lower_bound

Bilirubin 0 9 49 58 B-clinical_variable
< 10 11 59 60 O
1.5 12 15 61 64 B-upper_bound
x 16 17 65 66 I-upper_bound
the 18 21 67 70 I-upper_bound
upper 22 27 71 76 I-upper_bound
limit 28 33 77 82 I-upper_bound
of 34 36 83 85 I-upper_bound
normal 37 43 86 92 I-upper_bound
( 44 45 93 94 I-upper_bound
ULN 45 48 94 97 I-upper_bound
) 48 49 97 98 I-upper_bound

Bisphosphonates 0 15 99 114 B-treatment
are 16 19 115 118 O
permitted 20 29 119 128 O
, 29 30 128 129 O
including 31 40 130 139 O
pamidronate 41 52 140 151 B-treatment
, 52 53 151 152 O
zoledronic 54 64 153 163 B-treatment
acid 65 69 164 168 I-treatment
, 69 70 168 169 O
alendronate 71 82 170 181 B-treatment
, 82 83 181 182 O
ibandronate 84 95 183 194 B-treatment
, 95 96 194 195 O
risedronate 97 108 196 207 B-treatment

Bone 0 4 208 212 O
lesions 5 12 213 220 O
: 12 13 220 221 O
one 14 17 222 225 O
or 18 20 226 228 O
more 21 25 229 233 O
osteolytic 26 36 234 244 O
lesions 37 44 245 252 O
on 45 47 253 255 O
skeletal 48 56 256 264 B-treatment
radiography 57 68 265 276 I-treatment
, 68 69 276 277 O
computerized 70 82 278 290 B-treatment
tomography 83 93 291 301 I-treatment
( 94 95 302 303 I-treatment
CT 95 97 303 305 I-treatment
) 97 98 305 306 I-treatment
or 99 101 307 309 O
2 102 103 310 311 B-treatment
- 103 104 311 312 I-treatment
deoxy-2[F-18 104 116 312 324 I-treatment
] 116 117 324 325 I-treatment
fluoro 118 124 326 332 I-treatment
- 124 125 332 333 I-treatment
D 125 126 333 334 I-treatment
- 126 127 334 335 I-treatment
glucose 127 134 335 342 I-treatment
positron 135 143 343 351 I-treatment
emission 144 152 352 360 I-treatment
tomography 153 163 361 371 I-treatment
CT 164 166 372 374 I-treatment
( 167 168 375 376 I-treatment
PET 168 171 376 379 I-treatment
- 171 172 379 380 I-treatment
CT 172 174 380 382 I-treatment
) 174 175 382 383 I-treatment

Clonal 0 6 384 390 B-clinical_variable
bone 7 11 391 395 I-clinical_variable
marrow 12 18 396 402 I-clinical_variable
plasma 19 25 403 409 I-clinical_variable
cell 26 30 410 414 I-clinical_variable
percentage 31 41 415 425 I-clinical_variable
> 42 43 426 427 O
= 43 44 427 428 O
60 45 47 429 431 B-lower_bound
% 47 48 431 432 I-lower_bound

Concurrent 0 10 433 443 O
treatment 11 20 444 453 B-treatment
with 21 25 454 458 O
other 26 31 459 464 O
anti 32 36 465 469 B-treatment
- 36 37 469 470 I-treatment
cancer 37 43 470 476 I-treatment
therapy 44 51 477 484 I-treatment
is 52 54 485 487 O
not 55 58 488 491 O
permitted 59 68 492 501 O

Contraindication 0 16 502 518 O
to 17 19 519 521 O
any 20 23 522 525 O
concomitant 24 35 526 537 B-treatment
medication 36 46 538 548 I-treatment
, 46 47 548 549 O
including 48 57 550 559 O
pre 58 61 560 563 O
- 61 62 563 564 O
medications 62 73 564 575 O
or 74 76 576 578 O
hydration 77 86 579 588 O
given 87 92 589 594 O
prior 93 98 595 600 B-treatment
to 99 101 601 603 I-treatment
therapy 102 109 604 611 I-treatment

Creatinine 0 10 612 622 B-clinical_variable
clearance 11 20 623 632 I-clinical_variable
( 21 22 633 634 I-clinical_variable
CrCl 22 26 634 638 I-clinical_variable
) 26 27 638 639 I-clinical_variable
> 28 29 640 641 O
= 29 30 641 642 O
40 31 33 643 645 B-lower_bound
ml 34 36 646 648 I-lower_bound
/ 36 37 648 649 I-lower_bound
min 37 40 649 652 I-lower_bound

Females 0 7 653 660 B-gender
of 8 10 661 663 O
childbearing 11 23 664 676 O
potential 24 33 677 686 O
and 34 37 687 690 O
male 38 42 691 695 B-gender
subjects 43 51 696 704 I-gender
with 52 56 705 709 O
female 57 63 710 716 B-gender
partners 64 72 717 725 O
of 73 75 726 728 O
childbearing 76 88 729 741 O
potential 89 98 742 751 O
must 99 103 752 756 O
agree 104 109 757 762 B-contraception_consent
to 110 112 763 765 I-contraception_consent
avoid 113 118 766 771 I-contraception_consent
pregnancy 119 128 772 781 I-contraception_consent
by 129 131 782 784 I-contraception_consent
using 132 137 785 790 I-contraception_consent
an 138 140 791 793 I-contraception_consent
adequate 141 149 794 802 I-contraception_consent
method 150 156 803 809 I-contraception_consent
of 157 159 810 812 I-contraception_consent
contraception 160 173 813 826 I-contraception_consent
( 174 175 827 828 O
2 175 176 828 829 O
barrier 177 184 830 837 O
method 185 191 838 844 O
or 192 194 845 847 O
1 195 196 848 849 O
barrier 197 204 850 857 O
method 205 211 858 864 O
with 212 216 865 869 O
a 217 218 870 871 O
spermicide 219 229 872 882 O
or 230 232 883 885 O
intrauterine 233 245 886 898 O
device 246 252 899 905 O
for 253 256 906 909 O
2 257 258 910 911 B-upper_bound
weeks 259 264 912 917 I-upper_bound
prior 265 270 918 923 I-upper_bound
to 271 273 924 926 O
screening 274 283 927 936 O
, 283 284 936 937 O
during 285 291 938 944 O
and 292 295 945 948 O
12 296 298 949 951 B-upper_bound
weeks 299 304 952 957 I-upper_bound
after 305 310 958 963 O
the 311 314 964 967 O
last 315 319 968 972 O
dose 320 324 973 977 O
of 325 327 978 980 O
trial 328 333 981 986 O
medication 334 344 987 997 O
; 344 345 997 998 O
adequate 346 354 999 1007 O
methods 355 362 1008 1015 O
of 363 365 1016 1018 O
contraception 366 379 1019 1032 O
are 380 383 1033 1036 O
provided 384 392 1037 1045 O
as 393 395 1046 1048 O
examples 396 404 1049 1057 O
; 404 405 1057 1058 O
other 406 411 1059 1064 O
acceptable 412 422 1065 1075 O
and 423 426 1076 1079 O
effective 427 436 1080 1089 O
methods 437 444 1090 1097 O
of 445 447 1098 1100 O
birth 448 453 1101 1106 O
control 454 461 1107 1114 O
are 462 465 1115 1118 O
also 466 470 1119 1123 O
permitted 471 480 1124 1133 O
( 481 482 1134 1135 O
e.g. 482 486 1135 1139 O
, 486 487 1139 1140 O
abstinence 488 498 1141 1151 O
) 498 499 1151 1152 O

Hemoglobin 0 10 1153 1163 B-clinical_variable
more 11 15 1164 1168 O
or 16 18 1169 1171 O
equal 19 24 1172 1177 O
than 25 29 1178 1182 O
2 30 31 1183 1184 B-lower_bound
grams 32 37 1185 1190 I-lower_bound
/ 37 38 1190 1191 I-lower_bound
dL 38 40 1191 1193 I-lower_bound
below 41 46 1194 1199 O
the 47 50 1200 1203 O
institutional 51 64 1204 1217 O
level 65 70 1218 1223 O
of 71 73 1224 1226 O
normal 74 80 1227 1233 O

Hypercalcemia 0 13 1234 1247 B-chronic_disease
: 13 14 1247 1248 O
serum 15 20 1249 1254 B-clinical_variable
calcium 21 28 1255 1262 I-clinical_variable
> 29 30 1263 1264 O
0.25 31 35 1265 1269 B-lower_bound
mmol 36 40 1270 1274 I-lower_bound
/ 40 41 1274 1275 I-lower_bound
L 41 42 1275 1276 I-lower_bound
( 43 44 1277 1278 O
> 44 45 1278 1279 O
1 46 47 1280 1281 B-lower_bound
mg 48 50 1282 1284 I-lower_bound
/ 50 51 1284 1285 I-lower_bound
dL 51 53 1285 1287 I-lower_bound
) 53 54 1287 1288 O
higher 55 61 1289 1295 O
than 62 66 1296 1300 O
the 67 70 1301 1304 O
upper 71 76 1305 1310 O
limit 77 82 1311 1316 O
of 83 85 1317 1319 O
normal 86 92 1320 1326 O
or 93 95 1327 1329 O
> 96 97 1330 1331 O
2.75 98 102 1332 1336 B-lower_bound
mmol 103 107 1337 1341 I-lower_bound
/ 107 108 1341 1342 I-lower_bound
L 108 109 1342 1343 I-lower_bound
( 110 111 1344 1345 O
> 111 112 1345 1346 O
11 113 115 1347 1349 B-lower_bound
mg 116 118 1350 1352 I-lower_bound
/ 118 119 1352 1353 I-lower_bound
dL 119 121 1353 1355 I-lower_bound
) 121 122 1355 1356 O

Immunoparesis 0 13 1357 1370 O
( 14 15 1371 1372 O
this 15 19 1372 1376 O
term 20 24 1377 1381 O
refers 25 31 1382 1388 O
to 32 34 1389 1391 O
the 35 38 1392 1395 O
patient 39 46 1396 1403 O
having 47 53 1404 1410 O
low 54 57 1411 1414 O
uninvolved 58 68 1415 1425 O
immunoglobulins 69 84 1426 1441 O
in 85 87 1442 1444 O
peripheral 88 98 1445 1455 O
blood 99 104 1456 1461 O
, 104 105 1461 1462 O
for 106 109 1463 1466 O
example 110 117 1467 1474 O
if 118 120 1475 1477 O
a 121 122 1478 1479 O
patient 123 130 1480 1487 O
has 131 134 1488 1491 O
IgA 135 138 1492 1495 O
smoldering 139 149 1496 1506 B-cancer
multiple 150 158 1507 1515 I-cancer
myeloma 159 166 1516 1523 I-cancer
, 166 167 1523 1524 O
then 168 172 1525 1529 O
either 173 179 1530 1536 O
having 180 186 1537 1543 O
a 187 188 1544 1545 O
low 189 192 1546 1549 O
IgM 193 196 1550 1553 O
and/or 197 203 1554 1560 O
low 204 207 1561 1564 O
IgG 208 211 1565 1568 O
will 212 216 1569 1573 O
qualify 217 224 1574 1581 O
as 225 227 1582 1584 O
a 228 229 1585 1586 O
risk 230 234 1587 1591 O
factor 235 241 1592 1598 O
for 242 245 1599 1602 O
progression 246 257 1603 1614 O
to 258 260 1615 1617 O
multiple 261 269 1618 1626 O
myeloma 270 277 1627 1634 O
) 277 278 1634 1635 O

Intolerance 0 11 1636 1647 O
to 12 14 1648 1650 O
infused 15 22 1651 1658 O
protein 23 30 1659 1666 B-allergy_name
products 31 39 1667 1675 I-allergy_name
, 39 40 1675 1676 O
sucrose 41 48 1677 1684 B-allergy_name
, 48 49 1684 1685 O
histidine 50 59 1686 1695 B-allergy_name
or 60 62 1696 1698 O
polysorbate 63 74 1699 1710 B-allergy_name
80 75 77 1711 1713 I-allergy_name

Involved 0 8 1714 1722 O
: 8 9 1722 1723 O
uninvolved 10 20 1724 1734 O
serum 21 26 1735 1740 B-clinical_variable
free 27 31 1741 1745 I-clinical_variable
light 32 37 1746 1751 I-clinical_variable
chain 38 43 1752 1757 I-clinical_variable
ratio 44 49 1758 1763 I-clinical_variable
> 50 51 1764 1765 O
= 51 52 1765 1766 O
100 53 56 1767 1770 B-lower_bound
measured 57 65 1771 1779 O
by 66 68 1780 1782 O
freelite 69 77 1783 1791 O
assay 78 83 1792 1797 O

Known 0 5 1798 1803 O
human 6 11 1804 1809 B-chronic_disease
immunodeficiency 12 28 1810 1826 I-chronic_disease
virus 29 34 1827 1832 I-chronic_disease
( 35 36 1833 1834 I-chronic_disease
HIV 36 39 1834 1837 I-chronic_disease
) 39 40 1837 1838 I-chronic_disease
infection 41 50 1839 1848 I-chronic_disease

Major 0 5 1849 1854 B-treatment
surgery 6 13 1855 1862 I-treatment
within 14 20 1863 1869 O
1 21 22 1870 1871 B-upper_bound
month 23 28 1872 1877 I-upper_bound
prior 29 34 1878 1883 I-upper_bound
to 35 37 1884 1886 O
enrollment 38 48 1887 1897 O

Men 0 3 1898 1901 B-gender
must 4 8 1902 1906 O
agree 9 14 1907 1912 O
to 15 17 1913 1915 O
not 18 21 1916 1919 O
donate 22 28 1920 1926 O
sperm 29 34 1927 1932 O
while 35 40 1933 1938 O
on 41 43 1939 1941 O
the 44 47 1942 1945 O
study 48 53 1946 1951 O
and 54 57 1952 1955 O
for 58 61 1956 1959 O
at 62 64 1960 1962 O
least 65 70 1963 1968 O
3 71 72 1969 1970 B-lower_bound
months 73 79 1971 1977 I-lower_bound
after 80 85 1978 1983 O
the 86 89 1984 1987 O
last 90 94 1988 1992 O
dose 95 99 1993 1997 O
of 100 102 1998 2000 O
study 103 108 2001 2006 O
drug(s 109 115 2007 2013 O
) 115 116 2013 2014 O

Patients 0 8 2015 2023 O
must 9 13 2024 2028 O
have 14 18 2029 2033 O
histologically 19 33 2034 2048 O
confirmed 34 43 2049 2058 O
smoldering 44 54 2059 2069 B-cancer
multiple 55 63 2070 2078 I-cancer
myeloma 64 71 2079 2086 I-cancer
( 72 73 2087 2088 I-cancer
SMM 73 76 2088 2091 I-cancer
) 76 77 2091 2092 I-cancer

Patients 0 8 2093 2101 O
with 9 13 2102 2106 O
pre 14 17 2107 2110 O
- 17 18 2110 2111 O
existing 18 26 2111 2119 O
uncontrolled 27 39 2120 2132 O
pulmonary 40 49 2133 2142 B-chronic_disease
disease 50 57 2143 2150 I-chronic_disease
will 58 62 2151 2155 O
be 63 65 2156 2158 O
excluded 66 74 2159 2167 O
; 74 75 2167 2168 O
uncontrolled 76 88 2169 2181 O
refers 89 95 2182 2188 O
to 96 98 2189 2191 O
patients 99 107 2192 2200 O
having 108 114 2201 2207 O
had 115 118 2208 2211 O
at 119 121 2212 2214 O
least 122 127 2215 2220 O
one 128 131 2221 2224 B-lower_bound
hospitalization 132 147 2225 2240 O
due 148 151 2241 2244 O
to 152 154 2245 2247 O
pulmonary 155 164 2248 2257 O
disease 165 172 2258 2265 O
( 173 174 2266 2267 O
for 174 177 2267 2270 O
example 178 185 2271 2278 O
, 185 186 2278 2279 O
asthma 187 193 2280 2286 B-chronic_disease
, 193 194 2286 2287 O
chronic 195 202 2288 2295 B-chronic_disease
obstructive 203 214 2296 2307 I-chronic_disease
pulmonary 215 224 2308 2317 I-chronic_disease
disease 225 232 2318 2325 I-chronic_disease
) 232 233 2325 2326 O
within 234 240 2327 2333 O
the 241 244 2334 2337 O
6 245 246 2338 2339 B-upper_bound
months 247 253 2340 2346 I-upper_bound
prior 254 259 2347 2352 I-upper_bound
to 260 262 2353 2355 O
enrollment 263 273 2356 2366 O
in 274 276 2367 2369 O
the 277 280 2370 2373 O
study 281 286 2374 2379 O
; 286 287 2379 2380 O
patients 288 296 2381 2389 O
with 297 301 2390 2394 O
previous 302 310 2395 2403 O
history 311 318 2404 2411 O
of 319 321 2412 2414 O
pneumonitis 322 333 2415 2426 B-chronic_disease
will 334 338 2427 2431 O
be 339 341 2432 2434 O
excluded 342 350 2435 2443 O

Plasma 0 6 2444 2450 B-cancer
cell 7 11 2451 2455 I-cancer
leukemia 12 20 2456 2464 I-cancer

Pregnant 0 8 2465 2473 B-pregnancy
or 9 11 2474 2476 O
lactating 12 21 2477 2486 O
females 22 29 2487 2494 B-gender

Radiotherapy 0 12 2495 2507 B-treatment
is 13 15 2508 2510 O
not 16 19 2511 2514 O
permitted 20 29 2515 2524 O

Uncontrolled 0 12 2525 2537 O
intercurrent 13 25 2538 2550 O
illness 26 33 2551 2558 O
including 34 43 2559 2568 O
but 44 47 2569 2572 O
not 48 51 2573 2576 O
limited 52 59 2577 2584 O
to 60 62 2585 2587 O
active 63 69 2588 2594 B-chronic_disease
infection 70 79 2595 2604 I-chronic_disease
or 80 82 2605 2607 O
psychiatric 83 94 2608 2619 B-chronic_disease
illness 95 102 2620 2627 I-chronic_disease
/ 102 103 2627 2628 I-chronic_disease
social 103 109 2628 2634 I-chronic_disease
situations 110 120 2635 2645 I-chronic_disease
that 121 125 2646 2650 O
would 126 131 2651 2656 O
compromise 132 142 2657 2667 O
compliance 143 153 2668 2678 O
with 154 158 2679 2683 O
study 159 164 2684 2689 O
requirements 165 177 2690 2702 O

a 0 1 2703 2704 O
negative 2 10 2705 2713 B-pregnancy
urine 11 16 2714 2719 I-pregnancy
pregnancy 17 26 2720 2729 I-pregnancy
test 27 31 2730 2734 O
is 32 34 2735 2737 O
required 35 43 2738 2746 O
prior 44 49 2747 2752 O
to 50 52 2753 2755 O
each 53 57 2756 2760 O
subsequent 58 68 2761 2771 O
isatuximab 69 79 2772 2782 O
dose 80 84 2783 2787 O
administration 85 99 2788 2802 O

absence 0 7 2803 2810 O
of 8 10 2811 2813 O
myeloma 11 18 2814 2821 B-cancer
defining 19 27 2822 2830 O
events 28 34 2831 2837 O
or 35 37 2838 2840 O
amyloidosis 38 49 2841 2852 B-chronic_disease

